Coen Steven P., an officer at Ginkgo Bioworks Holdings, Inc., has sold 766 shares of the company. This transaction occurred on October 19, 2026, as part of a restricted stock vesting event. The sale underscores the ongoing executive activity within the life sciences sector, particularly in biological products.
Background
Ginkgo Bioworks Holdings, Inc. operates in the biological products sector, specifically classified under SIC 2836. The company was previously known as Soaring Eagle Acquisition Corp. and Spinning Eagle Acquisition Corp. Ginkgo Bioworks is incorporated in Delaware and has its headquarters at 27 Drydock Avenue, 8th Floor, Boston, MA. The company trades on the NYSE and has a Central Index Key (CIK) of 0001830214.
What the Filing Says
According to the recent SEC filing (accession number 0001959173-26-007422), Coen sold 766 shares of Class A stock, with an aggregate market value of approximately $7,769.23. The shares were acquired on October 16, 2026, through a restricted stock vesting process, which is part of his compensation package.
Impact
This sale may affect Ginkgo Bioworks' market perception, as executive stock transactions often draw attention from investors and analysts. The filing also indicates that Coen had previously sold shares on October 5, 2026, and August 24, 2026, as part of his ongoing stock liquidation strategy. The most recent sale included an amount necessary to cover a tax obligation related to the vested equity award distribution.
What's Next
The filing does not say what happens next.